A drug already used for osteoporosis blocked spinal damage in a new study
Genetic changes may set off a chain reaction that causes the spine’s natural shock absorbers to harden and deteriorate. Zebrafish with a faulty collagen-related gene developed mineral buildup and spinal fusion similar to human disc disease. Researchers were able to reduce the damage using an existing osteoporosis drug and by targeting fat metabolism. The discovery points to several exciting possibilities for future back pain treatments.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
Mosquitoes aren't just annoying - they kill around 700,000 people a year via the diseases they spread. But scientists ar…
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu seas…
The United Nations has set a goal for near universal HIV diagnosis and treatment for all by 2030. No country in Asia has…
The breakthrough that could end preeclampsia, a leading cause of maternal deaths National Geographic